Houn F - Search Results

1

Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention.

Brandenburg NA, Bwire R, Freeman J, Houn F, Sheehan P, Zeldis JB. Brandenburg NA, et al. Among authors: houn f. Drug Saf. 2017 Apr;40(4):333-341. doi: 10.1007/s40264-016-0501-2. Drug Saf. 2017. PMID: 28074423 Free PMC article.

2

Managing the teratogenic risk of thalidomide and lenalidomide: an industry perspective.

Bwire R, Freeman J, Houn F. Bwire R, et al. Among authors: houn f. Expert Opin Drug Saf. 2011 Jan;10(1):3-8. doi: 10.1517/14740338.2011.527331. Epub 2010 Dec 2. Expert Opin Drug Saf. 2011. PMID: 21121869 Review.

3

Teratogenic Drugs and Risk Management: An Implementation Assessment.

Freeman J, Bwire R, Houn F, Sheehan P, Backstrom J. Freeman J, et al. Among authors: houn f. Ther Innov Regul Sci. 2014 Jul;48(4):420-427. doi: 10.1177/2168479013516776. Ther Innov Regul Sci. 2014. PMID: 30235564

4

Considerations for licensure of influenza vaccines with pandemic and prepandemic indications.

Baylor NW, Houn F. Baylor NW, et al. Among authors: houn f. Curr Top Microbiol Immunol. 2009;333:453-70. doi: 10.1007/978-3-540-92165-3_22. Curr Top Microbiol Immunol. 2009. PMID: 19768419 Review.

5

Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue.

Faustino PJ, Yang Y, Progar JJ, Brownell CR, Sadrieh N, May JC, Leutzinger E, Place DA, Duffy EP, Houn F, Loewke SA, Mecozzi VJ, Ellison CD, Khan MA, Hussain AS, Lyon RC. Faustino PJ, et al. Among authors: houn f. J Pharm Biomed Anal. 2008 May 12;47(1):114-25. doi: 10.1016/j.jpba.2007.11.049. Epub 2007 Dec 14. J Pharm Biomed Anal. 2008. PMID: 18242038

6

The radioactive drug research committee: Background and retrospective study of reported research data (1975-2004).

Suleiman OH, Fejka R, Houn F, Walsh M. Suleiman OH, et al. Among authors: houn f. J Nucl Med. 2006 Jul;47(7):1220-6. J Nucl Med. 2006. PMID: 16818959 Free article.

7

Screening mammography: clinical image quality and the risk of interval breast cancer.

Taplin SH, Rutter CM, Finder C, Mandelson MT, Houn F, White E. Taplin SH, et al. Among authors: houn f. AJR Am J Roentgenol. 2002 Apr;178(4):797-803. doi: 10.2214/ajr.178.4.1780797. AJR Am J Roentgenol. 2002. PMID: 11906848

8

The FDA and The Lancet: an exchange.

Galson S, Kweder S, Houn F, Raczkowski V, Honig PK. Galson S, et al. Among authors: houn f. Lancet. 2001 Aug 4;358(9279):415; author reply 417-8. doi: 10.1016/S0140-6736(01)05560-X. Lancet. 2001. PMID: 11503619 No abstract available.

9

Study design in the evaluation of breast cancer imaging technologies.

Houn F, Bright RA, Bushar HF, Croft BY, Finder CA, Gohagan JK, Jennings RJ, Keegan P, Kessler LG, Kramer BS, Martynec LO, Robinowitz M, Sacks WM, Schultz DG, Wagner RF. Houn F, et al. Acad Radiol. 2000 Sep;7(9):684-92. doi: 10.1016/s1076-6332(00)80524-3. Acad Radiol. 2000. PMID: 10987329

10

Mammography in the 1990s: the United States and Canada.

Suleiman OH, Spelic DC, McCrohan JL, Symonds GR, Houn F. Suleiman OH, et al. Among authors: houn f. Radiology. 1999 Feb;210(2):345-51. doi: 10.1148/radiology.210.2.r99fe45345. Radiology. 1999. PMID: 10207413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page